Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Roche says weight loss drug shows promising results in early trial
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Social issues Health & Science Alphabet Inc
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Apple Inc Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Zealand Pharma A/S Amgen Inc Breaking news
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Novo Nordisk A/S Pharmaceuticals Earnings
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags US: News Health & Science Business
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Politics Social issues Health & Science
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Companies Social issues Breaking news
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Health care industry Morgan Stanley CAVA Group Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Biotechnology Business Health & Science
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Breaking news Companies Health care industry
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Companies Sanofi SA Health care industry
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Novo Nordisk A/S Europe News Health care industry
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Healthy Returns Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags Companies Health care industry US: News
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Companies Viking Therapeutics Inc Breaking news
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags stocks Meta Platforms Inc Personal investing
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Social issues Health & Science Biotechnology
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
Tags Business Stock markets Market Outlook
From CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
Tags Social issues Health & Science Business
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Salesforce Inc Health & Science Science
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags US: News Eli Lilly and Co Health & Science
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Novo Nordisk A/S Pharmaceuticals CNBC Changemakers
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.